Dan Rock is Chief Scientific Officer at Cartography, where he leads scientific operations and aligns strategy with the company’s mission. Previously, he was the Vice President of pharmacokinetics, metabolism, and bioanalytics at Merck and served as Global Head of pharmacokinetics and drug metabolism at Amgen. Over a 20+ year career, Dr. Rock has contributed to the design and optimization of 16 clinical-stage molecules, including bispecific T-cell engagers and ADCs. He has authored more than 70 publications and advanced in vitro technologies that accelerate biologic drug design. He earned a PhD in physical chemistry from Washington State University. Outside of work, he enjoys traveling with his family and bicycling.